Phagocytic cells, comprised of neutrophils and moncytyes/macrophages, play a key role in the innate immune response to infection. Our earlier study demonstrated that arabinoxylan rice bran (MGN-3/Biobran) activates murine peritoneal macrophage and macrophage cell lines. In this study, we investigated whether MGN-3 can up regulate the phagocytic activity of human phagocytes in peripheral blood to phagocytize Escherichia coli (E. colt), trigger the oxidative burst and produce cytokines. Phagocytic cells were pre-labeled with dichlorofluorescin diacetate dye and were incubated with phycoerythrin-labeledE. coli in the presence or absence of MGN-3. Phagocytosis and oxidative burst were assessed by flow cytometry, Results showed that treatment with MGN-3 enhanced the phagocytosis of E. coli by neutrophils and moncytes. This was associated with an increased oxidative burst. In addition, it caused a significant induction of cytokines (TNF-a, IL-6, IL-8 and IL-I0); the effect was detected at 1 Jlg/ml and increased in a dose-dependent manner (P~0.01). Notably, MGN-3 alone had no effect on the growth of 31 strains of bacteria suggesting that MGN-3 modulates phagocytic cellular function. These findings may have applications in the treatment of infections in the elderly and in immunocompromised patients.
Phagocytic cells, such as neutrophils and macrophages, are important components of the innate immune system that are necessary for the successful elimination of an infection. Phagocyte function is based on cellular activation characterized by phagocytosis, activation of the oxidative burst, and production of pro-inflammatory cytokines. Exposure of phagocytic cells to bacteria, or bacterial products, activates these cells which ultimately results in the clearance of pathogens (1). Stimulated macrophages can synthesize and release a large variety of cytokines including pro-and anti-inflammatory cytokines, and these cytokines play an important role in shaping the adaptive immune responses. Abnormalities in phagocytic cell functions are associated with increased susceptibility to infections. Therefore, agents that promote the functional activities of phagocytes are of great value in treating infections. . Many natural products have shown ability to activate macrophages. These include: a) algae like aphanizomenon fios-aquae (2); b) plants such as panax ginseng (3), shi-ka-ron and Chinese herbs (4), the roots of Platycodon grandiflorum (5) , and fermented papaya preparation (6) ; c) fungi such as lentinan isolated from Lentinus edodes (7) , prodigiosin from Serratia marcescens (8) , and schizophyllan from Schizophyllium commune (9) ; and d) bacteria such as bacillus Calmette Guerin (10) . Many polysaccharides extracted from these fungi and microbes exhibit immunomodulatory function through B(1, 3)-glucan. MGN-3/Biobran is a polysaccharide derived from rice bran (11) that has proven to be a novel biological response modifier (BRM). Oral intake of MGN-3 boosts the activity of human NK cells (12) (13) and the proliferation of T cells and B cells (11). Since in vitro studies have shown that MGN-3 augments thephagocytic activity of mouse macrophages against yeast (14) , this study was designed to investigate the ability of MGN-3 to enhance the functions of human phagocytes and to examine the mechanisms underlying its effect. The results show that MGN-3 exerts stimulatory effects on human phagocytic cells and enhances their oxidative burst and cytokine production (TNF-a, IL-6, IL-8, and IL-l 0). 
MATERIALS AND METHODS

Chemicals and bacteria
Media
Complete medium (CM) consisted of RPMI-1640, and was supplemented with 10 percent fetal calf serum (FCS), 2 mM glutamine, and 100 ug/ml streptomycin and penicillin.
MGN-3/Biobran
MGN-3 is an arabinoxylan extracted from rice bran that is treated enzymatically with an extract from shiitake mushrooms. It contains polysaccharides (B-I, 3-glucan and activated hemicellulose). (Daiwa Phann., Co., Ltd., Japan).
Culture ofMGN-3 with bacteria: cation-supplemented
Mueller Hinton broth (25 mg/L Ca++ and 12.5 mg/L Mg++) (CSMB) was used. The pH was measured after autoclaving and adjusted to 7.2-7.4 when necessary.
Propidium iodide labeling ofbacteria E. coli grown in peptone broth overnight were washed three times with HBSS without phenol red, fixed and penneabilized with 70% ethanol at 40°C for 30 minutes. The cells were then washed 2 times with phosphate buffered saline containing 1% gelatin and 1% glucose (PBSg) and re-suspended to a final concentration of 10 8 organisms per ml by optical density measurement at 580 nm in a spectrophotometer. The bacteria were then incubated with PI at a final concentration of 50 ug/ml for 30 min. The labeled bacteria were washed and resuspended in PBSg (108/ ml).
Phagocytosis
Whole blood (l ml) from 3 subjects was incubated with PI labeled E. coli for 1 hr at 37°C in the presence or absence ofMGN-3 (100 ug/ml), The uptake ofbacteria by neutrophils and monocytes/macrophages was detellllined by FACScan. Forward and Side Scatter was used to gate the monocytes and neutrophils. 10,000 cells were acquired and analyzed by the Cellquest Software Programme (BD Biosciences, San Jose, CA).
Assay ofoxidative productformation (ROS)
Intracellular production of hydrogen peroxide was measured by oxidation-dependent fluorescence of DCFH-DA. DCFH-DA is a cell-permeable and non-polar molecule. Inside the cell, the acetyl groups are cleaved by the cellular enzymes in the cytoplasm to produce the polar molecule DCFH, and then trapped inside the cells. DCFH-DA is a non-fluorescent molecule but its oxidation yields a fluorescent molecule which is readily detectable by flow cytometry. To load the cells with the dye, whole blood (l ml) from 5 subjects was incubated with 5 u.M of DCFH-DA for 15 minutes at 37°C. The cells were then washed with PBSg and incubated with MGN-3 (100 ug/ml) for 1 hr. DCFH fluorescence was detected by FACScan.
Cytokineproduction (TNF-a, 1L-6,1L-8 and 1L-10)
Peripheral blood mononuclear cells (PBMC). PBMC from 3 subjects in CM were cultured at 5 x 10 5 cells/0.6 ml/well of a 24-well plate in the presence of MGN-3 (1-1000 ug/ml). Culture supernatant obtained at 6 hrs after stimulation was assayed for tumor necrosis factora (TNF-a), and supernatants which were obtained at 24 hrs for interleukin-6 (IL-6), interleukin- 
Effect ofMGN-3 on oxidative burst
Oxidative burst in neutrophils and monocytes was monitored by measuring the production of hydrogen peroxide using DCFH Dye and FACScan. PMA was used as a positive control to determine the oxidative burst. Fig. 3 shows a representative flow cytograph of oxidative burst in neutrophils and monocytes cultured with E. coli in the presence or absence of MGN-3. In the presence of E. coli, MGN-3 increased oxidative burst in neutrophils and monocytes. Data in Fig. 4 show that MGN-3 alone had no effect on oxidative burst generation in either of the phagocytic cells.
Human macrophage cell line (U937 cells)
U937 cells in CM were pre-cultured with PMA (60 ng/ ml) for 3 days in a 24-well culture plate (2.5 x 10 5 cells/0.6 ml/well) to induce differentiation into macrophage-like cells. The adherent cells were cultured with MGN-3 (1-1000 ug/rnl) and cytokines in the culture supernatant were measured by ELISA as mentioned above.
manufacturer's instructions (Endogen, Woburn, MA), by use of matched antibody pairs. Quantification of each cytokine (in ng/ml) was performed based on the standard curve obtained in each assay.
Statistical analysis
All experiments were repeated at least three times. Student's t-test was used to assess the statistical significance of differences. Confidence level of <0.05 was considered significant.
In vitro activity ofMGN-3 against selected anaerobic and microaerobic bacteria
We performed time-kill studies with MGN-3 using standard procedure (15) (16) (17) as described in the Clinical Microbiology Procedure Handbook, Section 5.16.14. MGN-3 concentrations of 64, 256, and 1024 ug/ml were prepared in cation-supplemented Mueller Hinton broth. The pH of the solutions was measured at the starting time and at each sampling time. The MGN-3 and Levofloxacin, used as positive drug control, were added to flasks containing 10 ml of pre-warmed CSMB. The flasks were inoculated with the test strain to approximately 5x10 5 -Ix l Ovcfu/ml. A drug-free flask was included as a growth control. Incubation was at 37°C under aerobic conditions for 24 hrs. A small aliquot was removed at the "zero" time, diluted and plated to establish the starting concentration of the strain. All flasks were sampled after 2,4, 8, and 24 h incubation, diluted 10-or IOO-fold, and plated to determine the bacterial counts (cfu/ml). The pH was measured and recorded at each of these times. Levofloxacin was tested at 0.03 ug/ml for Escherichia coli, 2 ug/ml for Pseudomonas aeruginosa, 0.25 ug/ml for Staphylococcus aureus, and 1 ug/ml for Enterococcus faecalis.
RESULTS
Phagocytosis
A representative FACS histogram of lysed peripheral blood showing the forward and side scatter of different populations of phagocytes; polymorphonuclear leukocytes (PMN), monocytes and lymphocytes are shown in Fig. 1 . Whole blood was incubated with PI labeled E. coli in the presence
Effect of MGN-3 on production of cytokines (TNF-a, IL-6, IL-8, and IL-IO)
Experiments were carried out to in order to determine the effect of MGN-3 on cytokine production from human peripheral blood mononuclear cells and U937 cells. Cells were cocultured with MGN-3 (1-1000 ug/ml), cell culture supernatants were obtained at 6 or 24 hrs and were 
Cell st E.Col i Cell s t LColi t MGN-3 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _-l
Fig. 2. Effect ofMGN-3 on the phagocytic activity by PMN and monocytes. Whole blood (l ml) was incubated with PI labeled E. coli for 1 hr at 37°C in the presence or absence of MGN-3 (l00 ug/ml). The uptake of bacteria by phagocytic cells was determined by FACscan. Data represent mean±SD of3 subjects. *P <0.01 as compared to cells + E. coli alone.
assayed for the production ofTNF-a, IL-6, IL-8 and IL-I0 by ELISA. Data depicted in Fig. 5 show that MGN-3 treatment caused a significant enhancement in the production of these cytokines by PBMC and U937 cells (P:S 0.01); this was detected at 1 ug/ml and followed a dose dependent fashion, which was significant at concentrations of 10 ug/ml or higher (P< 0.01). In order to exclude a possibility that the increased production of cytokines was due to cell death and release of these cytokines, we examined the effect of MGN-3 on the viability of monocytes by PI technique using FACScan. The data shows that the viability of cells cultured with MGN-3 (87%) was similar to that of control cultures (90%).
In vitro activity of MGN-3 against selected anaerobic and microaerobic bacteria
A compound is usually considered to .be bactericidal if the starting inoculum is reduced by 3 loglo' i.e. from 10 5 to 10 2 cfu/ml. The results for each PMN Int . J. ImmunopathoJ. Pharmacol. strain at each compound concentration and the growth control were expressed as the cfu/ml at each time tested. A kill curve was constructed (4 strains, each with 3 concentrations of MGN-3; I Levofloxacin; I drug-free growth control = 5 flasks). Data in Table   I show a lack of activity by MGN-3 against a broad spectrum of anaerobic and microaerophilic bacteria as measured by the agar dilution technique. (18) and acts synergistically with yeast to induce apoptosis in cancer cells (19) . In addition, MGN-3 has proven to be a novel BRM that boosts the activity ofNK cells (12) (13) and T and B cell proliferation (11). Since in vitro studies have shown that MGN-3 augments the phagocytic activity of mouse macrophages against yeast (14) , this study was designed to investigate the ability of MGN-3 to enhance the functions of human PMN and monocytes. MGN-3 enhances phagocytosis of E. coli by human phagocytic cells and also enhances phagocytosis-induced oxidative burst. In addition, MGN-3 triggers the secretion of pro-and anti-inflammatory cytokines.
Oxidative burst in phagocytosis leads to the generation of reactive oxygen species, such as superoxide anion, which are potent antimicrobial compounds. In this study, we found MGN-3 had no direct killing effect on bacteria; however, it may increase intracellular killing by stimulating ROS. Upon activation with MGN-3, PBMC and U937 monocytic cell line produced several cytokines the effect of MGN-3 on U937 cell line, there is a change in the results of cytokine production, TNF and lL-6, from an earlier study published (14) which may be attributed to differences in the methods employed: U937 pre-cultured using PMA without dihydroxyvitamin D3, whereas it had been previously used. The precise mechanism(s) by which MGN-3 stimulates macrophage activities remains to be studied. MGN-3 is a polysaccharide that contains B-1, 3-g1ucan, and may function like many other polysaccharides extracted from many natural sources (the cell wall of fungi and certain bacteria), which have B-1, 3-g1ucans (7) (8) (9) (10) and are known to modulate innate immunity by binding to specific receptors on monocyte/ macrophages (24) and neutrophils (25) . Evidence suggests that there are multiple glucan-binding sites on macrophages including Type 3 complement receptor (CR3) (26) , non-CR3 glucan-binding sites (27) , and lactosylceramide (28) . Our findings that MGN-3 alone stimulated cytokine production, but not oxidative burst in phagocytic cells, would suggest that the signaling mechanisms for cytokine production are independent from that of oxidative burst.
We conclude that MGN-3 has an enhancing effect on antibacterial activity by human phagocytic cells. These data may suggest therapeutic properties of MGN-3 as an antimicrobial agent for the elderly.
